Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	6.85	91.21	85.37
Graham Fair Price	0.62	33.12	32.91
PEG	115.60	-10.07	4.67
Price/Book	2.76	13.53	13.16
Price/Cash Flow	-17.68	128.64	156.27
Prices/Earnings	9.80	29.36	26.74
Price/Sales	3.02	62.41	60.58
Price/FCF	-17.68	128.64	156.27
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-4.99	0.77	0.81
Operating Margin	-3.99	0.66	0.69
ROA	-5.66	0.05	0.05
ROE	0.12	0.12	-6.41
ROIC	0.08	0.08	0.89
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	0.01	-58.82
Dividends QOQ	0.16	0.02	-86.59
EBIT QOQ	0.07	-0.02	-66.77
EPS QOQ	0.06	-0.03	-49.07
FCF QOQ	-0.49	0.27	-45.03
Revenue QOQ	< 0.005	0.02	462.37
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	259.16	0.00	inf
Days Sales Outstanding (DSO)	52.44	59.79	14.02
Inventory Turnover	0.35	0.00	inf
Debt/Capitalization	0.34	0.34	-1.55
Quick Ratio	1.04	1.11	6.74
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	19.78	20.57	4.02
Cash	9.26	10.31	11.39
Capex	-0.13	-0.14	-7.44
Free Cash Flow	1.67	2.16	29.84
Revenue	4.30	4.46	3.75
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.45	1.40	-3.32
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.15	0.83	-27.63
Naive Interpretation	Member

06 - Financial Health · Weak

Rating